semaglutide gastrointestinal side effects What Are the Bad of Ozempic? Ozempic (semaglutide) is a GLP-1

By binding with GLP-1 receptors, semaglutide suppresses appetite, increases insulin secretion, delays gastric emptying, stimulates glucose-dependent sections of insulin, and reduces food intake to promote weight loss

You inject Thursday evening

When combined with insulin or sulfonylureas, dose adjustments of these medications are frequently necessary to reduce the risk of hypoglycemia, as the glucose-lowering effects may be additive

We encourage patients to have thorough discussions with their healthcare providers, addressing: Individual risk factors for vision problems Potential benefits of semaglutide for diabetes management or weight loss Alternative treatment options Monitoring strategies to detect early signs of eye complications For some patients, the benefits of improved blood sugar control or significant weight loss may outweigh the potential vision risks